Prot #0761-010: Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date2/12/132/12/19

Funding

  • Kyowa Hakko Kirin Pharma, Inc. (Prot #0761-010)